ANVISA Clarifies the Regulatory Boundary for Smart Rings and Medical Claims
ANVISA has clarified that smart rings currently marketed as wellness or sports products should not be used to diagnose disease, and that products presently available are not regularized for non-invasive glucose or oximetry measurement. The update reinforces that intended medical purpose and promotional claims can determine whether a wearable falls within the medical-device regulatory framework.